intensity-modulated radiotherapy
Showing 1 - 25 of >10,000
Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Dose-Painted Intensity Modulated Radiotherapy
-
Dublin, IrelandSt Luke's Radiation Oncology Network (SLRON)
Aug 29, 2023
Endometrial Cancer Trial in Seoul (POHIM_EM)
Recruiting
- Endometrial Cancer
- POHIM_EM
-
Seoul, Korea, Republic ofSamsung Medical Center
May 16, 2023
Rectal Cancer Trial (Trifluridine/Tipiracil, intensity-modulated radiotherapy)
Not yet recruiting
- Rectal Cancer
- Trifluridine/Tipiracil
- intensity-modulated radiotherapy
- (no location specified)
Jul 27, 2023
Prostate, Lung, Melanoma and Breast Cancer Patients Following
Recruiting
- Prostate Cancer
- +3 more
- SBRT
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Breast Carcinoma Trial in Ghent (radiation in prone position, radiation in supine position)
Completed
- Breast Carcinoma
- radiation in prone position
- radiation in supine position
-
Ghent, BelgiumUniversity Hospital Ghent
Dec 15, 2022
Nasopharyngeal Carcinoma, Intensity-Modulated Radiotherapy Trial in Zhongshan (Reduction CTVp1, Non-reduction CTVp1)
Recruiting
- Nasopharyngeal Carcinoma
- Intensity-Modulated Radiotherapy
- Reduction CTVp1
- Non-reduction CTVp1
-
Zhongshan, Guangdong, ChinaZhongshan City People's Hospital
Aug 8, 2023
Squamous Cell Carcinoma, Head Neck Cancer Trial in Tampa (Intensity-modulated radiotherapy, Magnetic Resonance Guidance)
Recruiting
- Squamous Cell Carcinoma
- Head and Neck Cancer
- Intensity-modulated radiotherapy
- Magnetic Resonance Guidance
-
Tampa, FloridaMoffitt Cancer Center
Nov 13, 2023
Acute Leukemia, Myelodysplastic Syndrome Trial in Duarte (Hematopoietic Cell Transplantation, Intensity-Modulated Radiation
Recruiting
- Acute Leukemia
- Myelodysplastic Syndrome
- Hematopoietic Cell Transplantation
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
- Radiotherapy
- Toripalimab
- (no location specified)
Mar 17, 2023
Sinonasal Malignancies:, Adenocarcinoma and Squamous Cell Carcinoma of the Paranasal Sinuses Trial in Heidelberg (carbon ion
Completed
- Sinonasal Malignancies
- Adenocarcinoma and Squamous Cell Carcinoma of the Paranasal Sinuses
- carbon ion boost
-
Heidelberg, GermanyDept of Radiation Oncology, University of Heidelberg, INF 400
Aug 29, 2022
Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)
Recruiting
- Rectal Neoplasms
- Tislelizumab
- +4 more
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Aug 27, 2023
Nasopharyngeal Carcinoma by AJCC V8 Stage Trial (New-mode reduce-volume target IMRT)
Not yet recruiting
- Nasopharyngeal Carcinoma by AJCC V8 Stage
- New-mode reduce-volume target IMRT
- (no location specified)
Oct 18, 2023
Head and Neck Squamous Cell Carcinoma Trial in Pittsburgh (Pembrolizumab, Cisplatin, IMRT)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Pembrolizumab
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Sep 15, 2022
Recurrent Head and Neck Carcinoma Trial in Houston (Intensity-Modulated Radiation Therapy, Proton Radiation, Stereotactic Body
Recruiting
- Recurrent Head and Neck Carcinoma
- Intensity-Modulated Radiation Therapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 16, 2022
Nasopharyngeal Carcinoma Trial in Guangzhou (drug, radiation, procedure)
Recruiting
- Nasopharyngeal Carcinoma
- Gemcitabine
- +4 more
-
Guangzhou, Guangdong, China
- +1 more
Jun 28, 2022
Breast Cancer Trial (myocardial perfusion SPECT)
Not yet recruiting
- Breast Cancer
- myocardial perfusion SPECT
- (no location specified)
Jul 7, 2022
Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester
Active, not recruiting
- Metastatic Prostate Adenocarcinoma
- +6 more
- Intensity-Modulated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Liposarcoma, Malignant Abdominal Tumor, Malignant Retroperitoneal Tumor Trial in Portland (drug, radiation, other, procedure)
Recruiting
- Liposarcoma
- +5 more
- Eribulin Mesylate
- +5 more
-
Portland, OregonOHSU Knight Cancer Institute
Oct 17, 2022
Recurrent Head and Neck Squamous Cell Carcinoma Trial in Atlanta, Cleveland, Milwaukee (IMRT, Nivolumab)
Active, not recruiting
- Recurrent Head and Neck Squamous Cell Carcinoma
- IMRT
- Nivolumab
-
Atlanta, Georgia
- +3 more
Jan 10, 2023
BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Thyroid Gland Anaplastic Carcinoma Trial in Duarte, Columbus (Dabrafenib,
Recruiting
- BRAF NP_004324.2:p.V600E
- +2 more
- Dabrafenib
- +2 more
-
Duarte, California
- +1 more
Jan 19, 2023
Esophagus Cancer Trial in Guangzhou (Cadonilimab, Paclitaxel and cisplatin, intensity-modulated radiotherapy)
Not yet recruiting
- Esophagus Cancer
- Cadonilimab
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University
Nov 20, 2023
Thyroid Cancer Stage IV, Radiation Toxicity Trial in Mumbai (Intensity Modulated Radiotherapy, Surgery alone)
Active, not recruiting
- Thyroid Cancer Stage IV
- Radiation Toxicity
- Intensity Modulated Radiotherapy
- Surgery alone
-
Mumbai, Maharashtra, IndiaGouri Pantvaidya
Apr 29, 2022
Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVB
Recruiting
- Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7
- +2 more
- Intensity-Modulated Radiation Therapy
- +4 more
-
Birmingham, Alabama
- +21 more
May 13, 2022
Nasopharyngeal Carcinoma Trial in Nanning (endostar, DDP, IMRT)
Completed
- Nasopharyngeal Carcinoma
- endostar
- +2 more
-
Nanning, Guangxi, ChinaThe First Affiliated Hospital of Guangxi Medical University
Jan 30, 2022